Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hazel pollen allergen refers to proteins in the pollen of hazel trees (*Corylus* species) that trigger allergic reactions in sensitized individuals. The major allergens include Cor a 1 (homologous to Bet v 1), Cor a 6, and Cor a 10. Exposure leads to allergic rhinitis, conjunctivitis, asthma, and dermatitis. Diagnosis involves specific IgE testing. Management includes avoidance, pharmacotherapy, and allergen immunotherapy.
Antihistamines: Block histamine receptors. Nasal corticosteroids: Reduce inflammation in nasal passages. Allergen immunotherapy: Induces tolerance to the allergen.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hazel Pollen Allergen.